Patent · US Expired

L-glutamic acid derivatives

US5013738A · kind A · utility

15Cited by
1References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 18, 1990
Grant dateMay 7, 1991
Priority date
Expiry dateApr 18, 2010

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Substituted pyrimidin-5-yl derivatives of L-glutamic acid are anti-neoplastic agents. A typical embodiment is N-{4-[6-(2,6-diamino-4-hydroxypyrimidin-5-yl)hex-1-en-3-yl]benzoyl}-L-glut amic acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.